Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

A big part of the problem is O'Connor lost Advaxis critical investor trust due to his unethical behavior, financial recklessness and self-dealing. That trust is very hard to regain especially for a clinical stage micro-cap biotech, which is why investors demanded an all time low $2 stock price to give Advaxis more capital. Berlin needs to show the market that he is ethical and aligned with investor interests (unlike O'Connor) and also that he is able to strike a non-dilutive monetary deal and not a lazy do-nothing (like Old Man Lombardo).